- Feature Paper
- Article
10 Citations
7,960 Views
17 Pages
Antibody Selection for Cancer Target Validation of FSH-Receptor in Immunohistochemical Settings
- Nina Moeker,
- Solveig Peters,
- Robert Rauchenberger,
- Nicolae Ghinea and
- Christian Kunz
Background: The follicle-stimulating hormone (FSH)-receptor (FSHR) has been reported to be an attractive target for antibody therapy in human cancer. However, divergent immunohistochemical (IHC) findings have been reported for FSHR expression in tumo...

